We’re proud to share that DeepRad.AI was awarded 3rd place in the Open Tech Pitching Session 2 at the SelectUSA Investment Summit 2025, hosted by the U.S. Department of Commerce!

 

Among top-tier global startups, this recognition reflects our team’s dedication and the growing international visibility of Taiwan’s medical AI innovation.

Our core product, DeepLung-CAC, uses AI to analyze low-dose chest CT scans and automatically generate structured diagnostic reports — improving early detection for lung cancer and cardiovascular risks, and supporting preventive care in aging societies.

We’re grateful for the support from Taiwan’s Ministry of Economic Affairs and SMEA, and look forward to expanding into the U.S. and global markets with impactful health tech solutions.